Superficial abdominal thrombophlebitis (Mondor's disease) presenting as loss of response to adalimumab in a Crohn's disease patient.
Department of Gastroenterology, Sheba Medical Center, Sackler School of Medicine, Tel-Aviv University, Tel-Hashomer, Israel. Electronic address: shomron.benhorin@gmail.com.
Shomron
S
Ben-Horin
Coagulation Unit, Hematology Department, Sheba Medical Center, Sackler School of Medicine, Tel-Aviv University, Tel-Hashomer, Israel.
Aaron
A
Lubetsky
Radiology Department, Sheba Medical Center, Sackler School of Medicine, Tel-Aviv University, Tel-Hashomer, Israel.
Zahava
Z
Heyman
Radiology Department, Sheba Medical Center, Sackler School of Medicine, Tel-Aviv University, Tel-Hashomer, Israel.
Yeroham
Y
Kleinbaum
D015746:Abdominal Pain / Q000209:etiology; D000068879:Adalimumab; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D004351:Drug Resistance; D006801:Humans; D008297:Male; D013924:Thrombophlebitis / Q000150:complications* / Q000000981:diagnostic imaging; D014463:Ultrasonography
D000894:Anti-Inflammatory Agents, Non-Steroidal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab
Anti-TNF; Crohn's disease; Thrombophlebitis; Thrombosis